Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95)

Diabetes Metab J. 2024 Jan;48(1):159-160. doi: 10.4093/dmj.2022.0458. Epub 2024 Jan 29.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucose
  • Humans
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucose
  • Sodium